Cell Reprogramming Market Share, Size, Trends, Industry Analysis Report, By Technology, By Application, By End-Use, By Region, Segment Forecast, 2022-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–Added the Cell Reprogramming Market Share, Size, Trends, Industry Analysis Report, By Technology, By Application, By End-Use, By Region, Segment Forecast, 2022-2030 report ResearchAndMarkets.com Offer.

According to a new study, the global cell reprogramming market is expected to reach USD 618.00 million by 2030. The report “Cell Reprogramming Market Share, Size, Trends, Industry Analysis Report, By Technology (Sendai Virus, mRNA, Episomal); by application (research, therapeutic); by end use; by region; Segment Forecast, 2022-2030” provides a detailed insight into the current market dynamics and offers analysis of future market growth.

Cell reprogramming has gained importance due to its ability to replace damaged cells or tissues, thereby reversing the adverse physiological effects it causes. Advances in related technologies such as progenitor cell creation, gene editing and tissue engineering have fueled the growth of the market.

Cellular reprogramming also has a significant impact on the diagnosis and treatment of human diseases. Increasing interest is driving the market among researchers in this field as it becomes possible to assess molecular biological mechanisms such as epigenetics, chromatin and differentiation in previously impossibly complex ways.

Regenerative medicine to provide a viable treatment advance in stem cell biology and increasing relevance of cell reprogramming in the healthcare sector are driving the growth of the market. Regulatory networks play a crucial role as Oct4 is widely considered to be the master gene for maintaining the pluripotent state of ES cells.

The Covid-19 pandemic had a positive impact on the market. Researchers have been involved in the development of novel drugs and treatments to combat Covid, and increased the use of cell reprogramming methods to create personalized medicines. Increased government and private investments have also fueled the growth of the market.

Highlights of the Cell Reprogramming market report

  • Based on the technology, mRNA reprogramming is expected to have the largest market share as it achieves more than 1% reprogramming efficiency without the use of viruses or DNA vectors.

  • The use of mRNA during reprogramming commits the need for the CMYC oncogene, making the generation of iPSCs safer. Their role as reprogramming enhancers allows mRNAs to increase reprogramming efficiency and reduce the number of required transfections associated with mRNAs.

  • The research segment is expected to account for a significant share as governments and private groups invest in stem cell research studies, strengthen industrial participants and secure a position in the global sector through the treatment of various chronic diseases.

  • An increasing number of strategic research and method efforts for innovative cell reprogramming products has fueled the growth of research and academic institutes and accounts for the largest market share driving the cell programming market.

  • North America is expected to take the largest market share as medical research has increased in the US leading to an increasing need for innovative treatment options.

The publisher has segmented the Cell Reprogramming Market report on the basis of Shape, Application, End-Use, and Region:

Cell Reprogramming, Technology Outlook (Revenue – $M, 2018 – 2030)

  • Sendai virus based rewrite

  • mRNA reprogramming

  • Episomal Reprogramming

  • Other

Cell Reprogramming, Application Outlook (Revenues – $M, 2018 – 2030)

Cell Reprogramming, End Use Outlook (Revenues – $M, 2018 – 2030)

  • research and academic institutes

  • biotechnology and pharmaceutical companies

  • hospitals and clinics

Cell Reprogramming, Regional Outlook (Revenues – $M, 2018 – 2030)

  • North America

  • US

  • Canada

  • Europe

  • Germany

  • United Kingdom

  • France

  • Italy

  • Spain

  • Russia

  • Netherlands

  • Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Indonesia

  • Malaysia

  • Latin America

  • Argentina

  • Brazil

  • Mexico

  • Middle East & Africa

  • UAE

  • Saudi Arabia

  • Israel

  • South Africa

Main topics covered:

1 Introduction

2. Summary

3. Research methodology

4. Global Cell Reprogramming Market Insights

5. Global Cell Reprogramming Market by Technology

6. Global Cell Reprogramming Market by Application

7. Global Cell Reprogramming Market by End-Use

8. Global Cell Reprogramming Market by Geography

9. Competitive Landscape

10. Company Profiles

companies mentioned

  • allelic biotechnology

  • ALSTEM

  • Applied biological materials

  • Axol Bioscience

  • Creative Bioarray

  • DefineGEN

  • Fujifilm Cellular Dynamics

  • lonza

  • mogrify

  • REPROCESS

  • stemnovating

  • ThermoFisher Scientific

For more information about this report, visit https://www.researchandmarkets.com/r/ljvpgl

source

Leave a Reply

Your email address will not be published. Required fields are marked *